Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D- glucuronide

Bioconjugate Chemistry

Volumn 22, Issue 4, 2011, Pages 752-758

  Fan, Jinda ^a   Brown, Sarah M ^b   Tu, Zhude ^a   Kharasch, Evan D ^b  

^a Department of Radiology ^*  (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; MASS SPECTROMETRY;

BUPRENORPHINE; ENZYME-ASSISTED; GLUCURONIDES; IN-VITRO; METHODS OF SYNTHESIS; OPIOIDS; PHARMACOLOGICAL ACTIVITY; PHASE II; TANDEM-MASS SPECTROMETRY; VITRO AND IN VIVO EXPERIMENT;

SYNTHESIS (CHEMICAL);

BUPRENORPHINE; NORBUPRENORPHINE; NORBUPRENORPHINE 3 BETA GLUCURONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL REACTION; CROSS COUPLING REACTION; DRUG ACTIVITY; DRUG METABOLISM; DRUG PURIFICATION; DRUG PURITY; DRUG SYNTHESIS; ENZYME SYNTHESIS; KOENIG KNORR COUPLING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; TANDEM MASS SPECTROMETRY;

CANIS FAMILIARIS;

EID: 79955010401     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100550u     Document Type: Article

References (36)

1. Kang, M. J., Song, W. H., Shim, B. H., Oh, S. Y., Lee, H. Y., Chung, E. Y., Sohn, Y., and Lee, J. (2010) Pharmacologically active metabolites of currently marketed drugs: Potential resources for new drug discovery and development Yakugaku Zasshi 130, 1325-1337
2. Coller, J., Christrup, L., and Somogyi, A. (2009) Role of active metabolites in the use of opioids Eur. J. Clin. Pharmacol. 65, 121-139
3. Paul, D., Standifer, K. M., Inturrisi, C. E., and Pasternak, G. W. (1989) Pharmacological characterization of morphine-6-ss-glucuronide, a very potent morphine metabolite J. Pharmacol. Exp. Ther. 251, 477-483 (Pubitemid 20005587)
4. Osborne, R., Thompson, P., Joel, S., Trew, D., Patel, N., and Slevin, M. (1992) The analgesic activity of morphine-6-glucuronide Br. J. Clin. Pharmacol. 34, 130-138
5. Dahan, A., van Dorp, E., Smith, T., and Yassen, A. (2008) Morphine-6-glucuronide (M6G) for postoperative pain relief Eur. J. Pain 12, 403-411 (Pubitemid 351312894)
6. Smith, T. W., Binning, A. R., and Dahan, A. (2009) Efficacy and safety of morphine-6-glucuronide (M6G) for postoperative pain relief: A randomized, double-blind study Eur. J. Pain 13, 293-299
7. van Dorp, E. L. A., Morariu, A., and Dahan, A. (2008) Morphine-6-glucuronide: Potency and safety compared with morphine Expert Opin. Pharmacother. 9, 1955-1961
8. Collins, G. B. and McAllister, M. S. (2007) Buprenorphine maintenance: A new treatment for opioid dependence Cleve. Clin. J. Med. 74, 514-520
9. Cone, E. J., Gorodetzky, C. W., Yousefnejad, D., Buchwald, W. F., and Johnson, R. E. (1984) The metabolism and excretion of buprenorphine in humans Drug Metab. Dispos. 12, 577-581 (Pubitemid 14020828)
10. Moody, D. E., Slawson, M. H., Strain, E. C., Laycock, J. D., Spanbauer, A. C., and Foltz, R. L. (2002) A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies Anal. Biochem. 306, 31-39 (Pubitemid 34722013)
11. McCance-Katz, E. F., Moody, D. E., Morse, G. D., Friedland, G., Pade, P., Baker, J., Alvanzo, A., Smith, P., Ogundele, A., Jatlow, P., and Rainey, P. M. (2006) Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine Clin. Infect. Dis. 43, S224-S234
12. Huang, W., Moody, D. E., and McCance-Katz, E. F. (2006) The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry Ther. Drug Monit. 28, 245-251 (Pubitemid 44314956)
13. McCance-Katz, E. F., Moody, D. E., Morse, G. D., Ma, Q., DiFrancesco, R., Friedland, G., Pade, P., and Rainey, P. M. (2007) Interaction between buprenorphine and atazanavir or atazanavir/ritonavir Drug Alcohol Depend. 91, 269-278 (Pubitemid 47539730)
14. Jensen, M. L., Foster, D., Upton, R., Grant, C., Martinez, A., and Somogyi, A. (2007) Comparison of cerebral pharmacokinetics of buprenorphine and norbuprenorphine in an in vivo sheep model Xenobiotica 37, 441-457 (Pubitemid 46572889)
15. Koenigs, W. and Knorr, E. (1901) Ueber einige derivate des traubenzuckers und der galactose Ber. Dtsch. Chem. Ges. 34, 957-981
16. Muller, T., Schneider, R., and Schmidt, R. R. (1994) Utility of glycosyl phosphites as glycosyl donors: Fructofuranosyl and 2-deoxyhexopyranosyl phosphites in glycoside bond formation Tetrahedron Lett. 35, 4763-4766
17. Soars, M. G., Mattiuz, E. L., Jackson, D. A., Kulanthaivel, P., Ehlhardt, W. J., and Wrighton, S. A. (2002) Biosynthesis of drug glucuronides for use as authentic standards J. Pharmacol. Toxicol. Methods 47, 161-168 (Pubitemid 36287356)
18. Soars, M. G., Ring, B. J., and Wrighton, S. A. (2003) The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases Drug Metab. Dispos. 31, 762-767 (Pubitemid 36617665)
19. Luukkanen, L., Kilpelainen, I., Kangas, H., Ottoila, P., Elovaara, E., and Taskinen, J. (1999) Enzyme-assisted synthesis and structural characterization of nitrocatechol glucuronides Bioconjugate Chem. 10, 150-154 (Pubitemid 29062532)
20. Kuuranne, T., Aitio, O., Vahermo, M., Elovaara, E., and Kostiainen, R. (2002) Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of methyltestosterone 17 alpha-methylandrost-4-en-17 beta-ol-3-one) and nandrolone (estr-4-en-17 beta-ol-3-one) metabolites Bioconjugate Chem. 13, 194-199 (Pubitemid 34267929)
21. Shute, R. E. and Rich, D. H. (1987) Synthesis and evaluation of novel activated mixed carbonate reagents for the introduction of the 2-(trimethylsilyl)ethoxycarbonyl(teoc)-protecting group Synthesis 346-349
22. ElSohly, M. A., Gul, W., Feng, S., and Murphy, T. P. (2005) Hydrolysis of conjugated metabolites of buprenorphine ii. The quantitative enzymatic hydrolysis of norbuprenorphine-3-β-D-glucuronide in human urine J. Anal. Toxicol. 29, 570-573 (Pubitemid 41595472)
23. Lewis, P., Kaltia, S., and Wahala, K. (1998) The phase transfer catalysed synthesis of isoflavone-O-glucosides J. Chem. Soc., Perkin Trans. 1 2481-2484 (Pubitemid 128759758)
24. Carpino, L. A., Tsao, J. H., Ringsdorf, H., Fell, E., and Hettrich, G. (1978) The β-(trimethylsilyl)ethoxycarbonyl amino-protecting group J. Chem. Soc., Chem. Commun. 358-359
25. Trost, B. M. and Romero, A. G. (1986) Synthesis of optically-active isoquinuclidines utilizing a diastereoselectivity control element J. Org. Chem. 51, 2332-2342
26. 1 J. Am. Chem. Soc. 77, 3310-3315
27. Bowering, W. D. S. and Timell, T. E. (1960) Synthesis and characterization of 2- O -(β-D-glucopyranosyluronic acid)-D-xylopyranose J. Am. Chem. Soc. 82, 2827-2830
28. Biesalski, H. K., Doepner, G., Kunz, H., Paust, J., and John, M. (1995) Convenient synthesis of biologically important retinoids Liebigs Ann. 717-720
29. Tajima, K. (1986) Anomer-specificity in the degradation reaction of d-glucopyranuronic acid tetraacetate leading to comanic acid in the acetic anhydride-base system Tetrahedron Lett. 27, 6095-6098
30. Chang, Y. and Moody, D. E. (2009) Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases Drug. Metab. Lett. 3, 101-107
31. Abbo, L. A., Ko, J. C., Maxwell, L. K., Galinsky, R. E., Moody, D. E., Johnson, B. M., and Fang, W. B. (2008) Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs Vet. Ther. 9, 83-93
32. Hanninen, O. and Puukka, R. (1971) Activation of microsomal UDP glucuronyltransferase by phospholipases Chem.-Biol. Interact 3, 282-284
33. Temple, A. R., George, D. J., and Done, A. K. (1971) Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) enhancement of p-nitrophenol glucuronidation Biochem. Pharmacol. 20, 1718-1720
34. Zakim, D. and Dannenberg, A. J. (1992) How does the microsomal membrane regulate UDP-glucuronosyltransferases? Biochem. Pharmacol. 43, 1385-1393
35. Kilford, P. J., Stringer, R., Sohal, B., Houston, J. B., and Galetin, A. (2009) Prediction of drug clearance by glucuronidation from in vitro data: Use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes Drug Metab. Dispos. 37, 82-89
36. Linder, C. D., Renaud, N. A., and Hutzler, J. M. (2009) Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Drug Metab. Dispos. 37, 10-13